Susanne Singer1,2, Julia Roick3, Helge Danker4, Rolf-Dieter Kortmann5, Kirsten Papsdorf5, Sabine Taubenheim6, Mirjam Renovanz7, Katja Jähne8, Jürgen Meixensberger8. 1. Division of Epidemiology and Health Services Research, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Centre, Obere Zahlbacher Straße 69, 55131, Mainz, Germany. singers@uni-mainz.de. 2. University Cancer Centre, Mainz, Germany. singers@uni-mainz.de. 3. Department of Medical Sociology, University Medical Centre, Halle, Germany. 4. Department of Medical Psychology and Medical Sociology, University Medical Centre, Leipzig, Germany. 5. Department of Radiation-Oncology, University Medical Centre, Leipzig, Germany. 6. Regional Clinical Cancer Registry, Leipzig, Germany. 7. Department of Neurosurgery, University Medical Centre, Mainz, Germany. 8. Department of Neurosurgery, University Medical Centre, Leipzig, Germany.
Abstract
BACKGROUND: Distress impacts the daily life of glioma patients. This study explored its course over time and the usage of psychosocial care. METHODS: A consecutive sample of glioma patients completed the Hospital Anxiety and Depression Scale to assess distress levels at admission to the hospital (t1), before discharge (t2), after 3 months (t3), and after 6 months (t4). They were interviewed with the Structured Clinical Interview for DSM-IV to ascertain psychiatric disorders at t2. Psycho-oncological care in the hospital was determined with the Hospital Information System, and the use of outpatient treatment was evaluated with the Health Care Usage Questionnaire at t4. We compared the percentages of elevated distress, psychiatric co-morbidity, and care usage between men and women. RESULTS: During the study period, 37 patients were enrolled. Nineteen percent of the patients were diagnosed with a psychiatric disorder. The percentages of patients with elevated distress were 56, 59, 39, and 40% at t1, t2, t3, and t4, respectively. Participants who did not survive the 6 months presented with higher levels of distress. In the hospital, 14% of those with elevated distress were visited by a psycho-oncologist. In the outpatient setting, 43% of those with elevated distress visited a neuro-psychiatrist, and 14% went to a psychotherapist. There was no evidence for an effect of gender on psychiatric co-morbidity, distress, or care use. CONCLUSIONS: A significant proportion of glioma patients report elevated distress during the hospital stay and thereafter. Only a fraction of them receive mental health care.
BACKGROUND: Distress impacts the daily life of gliomapatients. This study explored its course over time and the usage of psychosocial care. METHODS: A consecutive sample of gliomapatients completed the Hospital Anxiety and Depression Scale to assess distress levels at admission to the hospital (t1), before discharge (t2), after 3 months (t3), and after 6 months (t4). They were interviewed with the Structured Clinical Interview for DSM-IV to ascertain psychiatric disorders at t2. Psycho-oncological care in the hospital was determined with the Hospital Information System, and the use of outpatient treatment was evaluated with the Health Care Usage Questionnaire at t4. We compared the percentages of elevated distress, psychiatric co-morbidity, and care usage between men and women. RESULTS: During the study period, 37 patients were enrolled. Nineteen percent of the patients were diagnosed with a psychiatric disorder. The percentages of patients with elevated distress were 56, 59, 39, and 40% at t1, t2, t3, and t4, respectively. Participants who did not survive the 6 months presented with higher levels of distress. In the hospital, 14% of those with elevated distress were visited by a psycho-oncologist. In the outpatient setting, 43% of those with elevated distress visited a neuro-psychiatrist, and 14% went to a psychotherapist. There was no evidence for an effect of gender on psychiatric co-morbidity, distress, or care use. CONCLUSIONS: A significant proportion of gliomapatients report elevated distress during the hospital stay and thereafter. Only a fraction of them receive mental health care.
Authors: Neil K Aaronson; Martin J B Taphoorn; Jan J Heimans; Tjeerd J Postma; Chad M Gundy; Guus N Beute; Ben J Slotman; Martin Klein Journal: J Clin Oncol Date: 2011-10-17 Impact factor: 44.544
Authors: Kristina Geue; Robert Richter; Marianne Buttstaedt; Elmar Braehler; Ursula Boehler; Susanne Singer Journal: Support Care Cancer Date: 2011-01-27 Impact factor: 3.603
Authors: N K Aaronson; S Ahmedzai; B Bergman; M Bullinger; A Cull; N J Duez; A Filiberti; H Flechtner; S B Fleishman; J C de Haes Journal: J Natl Cancer Inst Date: 1993-03-03 Impact factor: 13.506
Authors: Florien W Boele; Cornelia F van Uden-Kraan; Karen Hilverda; Jaap C Reijneveld; Wilmy Cleijne; Martin Klein; Irma M Verdonck-de Leeuw Journal: Support Care Cancer Date: 2016-02-15 Impact factor: 3.603
Authors: Sebastian Otto-Meyer; Jan Lumibao; Eugene Kim; Erik Ladomersky; Lijie Zhai; Kristen L Lauing; Denise M Scholtens; Frank Penedo; Christina Amidei; Rimas V Lukas; Derek A Wainwright Journal: Curr Opin Behav Sci Date: 2019-02-26
Authors: Christiane Reinert; Michael Gerken; Katharina Rathberger; Katharina Krueger; Monika Klinkhammer-Schalke; Patricia Lindberg-Scharf; Oliver Koelbl; Martin A Proescholdt; Markus J Riemenschneider; Tobias Pukrop; Elisabeth Bumes; Markus Hutterer; Peter Hau Journal: BMC Psychol Date: 2020-09-10